<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
Commission File No. 0-16286
NOTIFICATION OF LATE FILING
(Check one):
[ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [X] Form 10-Q [ ] Form N-SAR
For Period Ended: December 31, 1995
Read Attached Instruction Sheet Before Preparing Form. Please Print or Type.
Nothing in this Form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
PART I - REGISTRANT INFORMATION
Full Name of Registrant: MEDPLUS CORPORATION
Former Name if Applicable N/A
Address of Principal Executive Office: 8 S. Nevada Ave., Suite 500
City, State and Zip Code Colorado Springs, Colorado 80903
PART II - RULES 12b - 25(b) and (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b - 25 (b), the
following should be completed. (Check box if appropriate)
[X] (a) The reasons described in reasonable detail in Part III of this
Form could not be eliminated without unreasonable effort or
expense.
<PAGE>
[ ] (b) The subject annual or semiannual report/portion thereof will be
filed on or before the fifteenth calendar day following the
prescribed due date, or the subject quarterly report/portion
thereof will be filed on or before the fifth calendar day
following the prescribed period due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule
12b - 25 (c) has been attached if applicable.
PART III - NARRATIVE
State in reasonable detail the reasons why the Form 10-K, 11-K, 20-F, 10-Q,
or N-SAR or portion thereof could not be filed within the prescribed time
period.
Due to complications beyond the control of management in completing financial
statements, the Company is unable to make a timely disclosure and requires
additional time in which to complete its Report on Form 10-Q. The Company
expects to file its Report on Form 10-Q within 5 days by February 20, 1996.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification.
(Name) (Area Code) (Telephone No.)
Robert T. Ryman 719 575-0044
(2) Have all other periodic reports required under Section 13 or 15(d)
of the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter
period that the registrant was required to file such reports been
filed? If answer no, identify report(s).
[X] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject
report or portion thereof?
[ ] Yes [X] No
If so: Attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made.
(2)
<PAGE>
MEDPLUS CORPORATION
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: February 12, 1996 BY: /s/ ROBERT T. RYMAN
-----------------------------------
NAME: Robert T. Ryman
TITLE: Chief Financial Officer
(3)
